NRC Health NRC
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.50% | 1.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.50% | 1.69% | |||
| Cost of Revenue | 13.37% | -0.60% | |||
| Gross Profit | 5.47% | 3.17% | |||
| SG&A Expenses | -39.12% | 47.44% | |||
| Depreciation & Amortization | -2.50% | -2.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.86% | 21.33% | |||
| Operating Income | 11,520.51% | -101.40% | |||
| Income Before Tax | 263.15% | -203.61% | |||
| Income Tax Expenses | 315.15% | -208.38% | |||
| Earnings from Continuing Operations | 243.28% | -201.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 243.28% | -201.89% | |||
| EBIT | 11,520.51% | -101.40% | |||
| EBITDA | 437.25% | -73.60% | |||
| EPS Basic | 244.10% | -205.93% | |||
| Normalized Basic EPS | 644.76% | -131.13% | |||
| EPS Diluted | 239.91% | -207.21% | |||
| Normalized Diluted EPS | 640.66% | -131.31% | |||
| Average Basic Shares Outstanding | -1.29% | 0.96% | |||
| Average Diluted Shares Outstanding | -0.55% | 0.45% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.69% | -1.98% | |||